EFFECT OF LUNASIN-RICH SOYBEAN EXTRACT UPON TNF-α EXPRESSION ON COLONIC EPITHELIAL CELLS OF MICE INDUCED BY AZOXYMETHANE/DEXTRAN SODIUM SULFATE
Objective: Colorectal cancer (CRC) contributes to 9.7% of all cancer, and its pathogenesis is related to chronic inflammation. However, current cancer therapy options are lacking, and peptide in food has become popular among researchers because it is cheap, easy to get, has a low toxicity, and is a promising cancer-preventing agent. This research aimed to investigate whether lunasin from soybeans can reduce the expression of pro-inflammatory cytokine TNF-α in colonic epithelial cells.
Methods: Thirty Swiss Webster mice were randomly allocated to six groups. One group was normal, and in five groups, carcinogenesis was induced using azoxymethane (AOM) and dextran sodium sulfate (DSS). The mice were then given nothing (negative control), aspirin (positive control), and lunasin-rich soybean extract (LSE) in three different doses (250, 300, and 350 mg/kgBW) for four weeks. Distal colon tissue was immunohistochemically stained and then observed under a light microscope with 400X magnification to count epithelial cells, based on their color. The index was calculated using optical density scores.
Results: LSE was shown to decrease the expression of tumor necrosis factor (TNF)-α. This decrease was statistically significant between the negative control and a dose of 300 mg/kgBW (p=0.016) and 350 mg/kgBW (p=0.009), yet it was not significant with a dose of 250 mg/kgBW (p=0.754).
Conclusion: a dose of 300 mg/kgBW or higher of LSE can reduce the expression of TNF-α.
2. GLOBOCAN. Estimated cancer incidence, mortality and prevalence in. International Agency for Research on Cancer: WHO; 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx [Last accessed on 02 Dec 2012]
3. Tuan J, Chen YX. Dietary and lifestyle factors associated with colorectal cancer risk and interactions with microbiota: fiber, red or processed meat and alcoholic drinks. Gastrointest Tumors 2016;3:17–24.
4. Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 2013;24:1207–22.
5. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics. CA Cancer J Clin 2017;67:177–93.
6. Bhutia SK, Maiti TK. Targeting tumors with peptides from natural sources. Trends Biotechnol 2008;26:210–7.
7. Galvez AF, Chen N, Macasieb J, de Lumen BO. Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 2001;61:7473–8.
8. Mejia EGD, Dia VP. The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells. Cancer Metastasis Rev 2010;29:511–28.
9. Aluko RE. Functional foods and nutraceuticals. 1st ed. New York (NY): Springer; 2012. p. 92–5.
10. Hernández Ledesma B, Hsieh C, Lumen BO. Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun 2009;390:803–8.
11. Seber LE, Barnett BW, McConnell EJ, Hume SD, Cai J, Boles K, et al. Scalable purification and characterization of the anticancer lunasin peptide from soybean. PLoS One 2012;7:e35409.
12. Dia VP, Wang W, Oh VL, de Lumen BO, de Mejia EG. Isolation, purification and characterisation of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity. Food Chem 2009;114:108–15.
13. Kusmardi, Priosoeryanto B, Harlina E, Cornain S. Inhibition activities of fish oil in iNOs, COX-2, and ?-Catenin expressions in colorectal preneoplasia of mice induced by azoxymethane and dextran sodium sulfate. J Appl Biotechnol 2014;2:91.
14. Costa D, Carvalho J. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 2012;18:3831–52.
15. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996;39:87–92.
16. Parang B, Barrett CW, Williams CS. AOM/DSS model of colitis-associated cancer. Methods Mol Biol 2016;1422:297–307.
17. Amalia AW, Kusmardi, Elya B, Arsianti A. Inhibition of carcinogenesis by seed and soybean meal extract in colon of mice: apoptosis and dysplasia. Asian J Pharm Clin Res 2017;10:123.
18. Monteleone G, Pallone F, Stolfi C. The dual role of inflammation in colon carcinogenesis. Int J Mol Sci 2012;13:11071–84.
19. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, et al. Nuclear factor ?B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998;115:357–69.
20. Garcia Albeniz X, Chan AT. Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol 2011;25:461–72.
21. Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Br J Cancer 2014;111:61–7.
22. Liu J, Jia S, Kirberger M, Chen N. Lunasin as a promising health-beneficial peptide. Eur Rev Med Pharmacol Sci 2014;18:2070–5.
23. de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-?B pathway in the macrophage. Peptides 2009;30:2388–98.
This work is licensed under a Creative Commons Attribution 4.0 International License.